Sotaro Enatsu
Sotaro Enatsu publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies and Lung Cancer Research Studies.
- World rank
- #3,798,364 of 7,710,434 ranked researchers
- Rank in Japan
- #98,203 of 383,136
- Works
- 81
- Citations
- 1.7k
- Citations per work
- 20.8
What does Sotaro Enatsu research?
Sotaro Enatsu's work is mostly in Medicine (78%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6378.2%
- Medicine6378.2%
- Life Sciences911.1%
- Everything else910.7%
- 1Pulmonary and Respiratory Medicine39% of their works
- 2Oncology34% of their works
- 3Molecular Biology6% of their works
- 4Cancer Research5% of their works
- 5Radiology, Nuclear Medicine and Imaging3% of their works
- 6Surgery2% of their works
Research topics
Which keywords describe Sotaro Enatsu's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Cetuximab, KRAS Mutations and Genomic Profiles.
- HER2
- Breast Cancer
- Cancer Genomics
- Immune Checkpoint Blockade
- CT Screening
- Genomic Profiles
- Cetuximab
- ALK Inhibitors
- Clinical Trials
- Targeted Therapy
- Chemotherapy
- EGFR Mutations
- KRAS Mutations
- Small-Cell Lung Cancer
- Lung Cancer
- PD-1 and PD-L1
- Mutational Signatures
- Chemotherapy-Induced Peripheral Neuropathy
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Targeted Therapy753 topics
- Clinical Trials682 topics
- Chemotherapy634 topics
- ALK Inhibitors511 topic
- EGFR Mutations511 topic
- Cetuximab261 topic
- KRAS Mutations261 topic
- Genomic Profiles171 topic
- Small-Cell Lung Cancer171 topic
- CT Screening141 topic
- Lung Cancer141 topic
- Immune Checkpoint Blockade81 topic
- PD-1 and PD-L181 topic
- Cancer Genomics71 topic
- Mutational Signatures71 topic
- Breast Cancer61 topic
- Chemotherapy-Induced Peripheral Neuropathy61 topic
- HER261 topic
- Taxanes61 topic
Where does Sotaro Enatsu work?
Sotaro Enatsu's main affiliation in the publication record is Eli Lilly (Japan), Japan.
How many publications and citations does Sotaro Enatsu have?
OpenAlex counts 81 works and 1,682 citations for Sotaro Enatsu, an h-index of 16, ranking #3,798,364 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sotaro Enatsu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.